Skip to main content
Log in

Cancer risk in a cohort of subjects carrying a single mismatch repair gene mutation

  • Published:
Familial Cancer Aims and scope Submit manuscript

Abstract

Hereditary non-polyposis colon cancer (HNPCC) is an autosomal dominant condition, caused by germline mutations in the mismatch repair genes, that presents with colorectal cancers at a young age, as well as extracolonic tumours. One of the causative mutations is the C1528T (Exon 13) mutation of the MLH1 gene. The purpose of this study is to document the cancer risk for subjects who carry this mutation. This is a prospective cohort study of 200 subjects who carry this mutation. We calculated the risk of developing colorectal cancer only in those subjects who had not undergone surveillance colonoscopy. The incidence of extracolonic cancers (for which surveillance is not routinely offered) was determined for the entire cohort. The results of the study are among the 71 subjects who did not undergo surveillance colonoscopy, colorectal cancers occurred in 36 (51%). They occurred at a median age of 44 years (range 17–73). Using Kaplan–Meier estimates, the risk of developing a colorectal cancer by age 65 was 92%. Eighteen subjects in the cohort of 200 were diagnosed with extracolonic tumours. The most common extracolonic malignancies were breast (6/98 women) and endometrial (3/98 women). Thus this mutation has a high penetrance for colorectal cancer, but is not associated with a high risk of developing extracolonic malignancies.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Watson P, Riley B (2005) The tumor spectrum in the Lynch syndrome. Fam Cancer 4(3):245–248

    Article  PubMed  Google Scholar 

  2. Ramesar RS, Madden MV, Felix R, Harocopos CJ, Westbrook CA, Jones G, Cruse JP, Goldberg PA (2000) Molecular genetics improves the management of hereditary non-polyposis colorectal cancer. S Afr Med J 90(7):709–714

    CAS  PubMed  Google Scholar 

  3. Goldberg PA, Madden MV, Harocopos C, Felix R, Westbrook C, Ramesar RS (1998) In a resource-poor country, mutation identification has the potential to reduce the cost of family management for hereditary nonpolyposis colorectal cancer. Dis Colon Rectum 41(10):1250–1253

    Article  CAS  PubMed  Google Scholar 

  4. Anderson DW, Goldberg PA, Algar U, Felix R, Ramesar RS (2007) Mobile colonoscopic surveillance provides quality care for hereditary nonpolyposis colorectal carcinoma families in South Africa. Colorectal Dis 9(6):509–514

    Article  CAS  PubMed  Google Scholar 

  5. Aarnio M, Mecklin JP, Aaltonen LA, Nyström-Lahti M, Järvinen HJ (1995) Life-time risk of different cancers in hereditary non-polyposis colorectal cancer (HNPCC) syndrome. Int J Cancer 64(6):430–433

    Article  CAS  PubMed  Google Scholar 

  6. Vasen HF, Wijnen JT, Menko FH, Kleibeuker JH, Taal BG, Griffioen G, Nagengast FM, Meijers-Heijboer EH, Bertario L, Varesco L, Bisgaard ML, Mohr J, Fodde R, Khan PM (1996) Cancer risk in families with hereditary nonpolyposis colorectal cancer diagnosed by mutation analysis. Gastroenterology 110(4):1020–1027

    Article  CAS  PubMed  Google Scholar 

  7. Dunlop MG, Farrington SM, Carothers AD, Wyllie AH, Sharp L, Burn J, Liu B, Kinzler KW, Vogelstein B (1997) Cancer risk associated with germline DNA mismatch repair gene mutations. Hum Mol Genet 6(1):105–110

    Article  CAS  PubMed  Google Scholar 

  8. Jäger AC, Bisgaard ML, Myrhøj T, Bernstein I, Rehfeld JF, Nielsen FC (1997) Reduced frequency of extracolonic cancers in hereditary nonpolyposis colorectal cancer families with monoallelic hMLH1 expression. Am J Hum Genet 61(1):129–138

    Article  PubMed  Google Scholar 

  9. Aarnio M, Sankila R, Pukkala E, Salovaara R, Aaltonen LA, de la Chapelle A, Peltomäki P, Mecklin JP, Järvinen HJ (1999) Cancer risk in mutation carriers of DNA-mismatch-repair genes. Int J Cancer 81(2):214–218

    Article  CAS  PubMed  Google Scholar 

  10. Vasen HF, Stormorken A, Menko FH, Nagengast FM, Kleibeuker JH, Griffioen G, Taal BG, Moller P, Wijnen JT (2001) MSH2 mutation carriers are at higher risk of cancer than MLH1 mutation carriers: a study of hereditary nonpolyposis colorectal cancer families. J Clin Oncol 19(20):4074–4080

    CAS  PubMed  Google Scholar 

  11. Parc Y, Boisson C, Thomas G, Olschwang SJ (2003) Cancer risk in 348 French MSH2 or MLH1 gene carriers. Med Genet 40(3):208–213

    Article  CAS  Google Scholar 

  12. Barrow E, Robinson L, Alduaij W, Shenton A, Clancy T, Lalloo F, Hill J, Evans DG (2009) Cumulative lifetime incidence of extracolonic cancers in Lynch Syndrome: a report of 121 families with proven mutations. Clin Genet 75:141–149

    Article  CAS  PubMed  Google Scholar 

  13. Stupart DA, Goldberg PA, Algar U, Ramesar R (2009) Surveillance colonoscopy improves survival in a cohort of subjects with a single mismatch repair gene mutation. Colorectal Dis 11(2):126–130

    Article  CAS  PubMed  Google Scholar 

  14. Quehenberger F, Vasen HF, van Houwelingen HC (2005) Risk of colorectal and endometrial cancer for carriers of mutations of the hMLH1 and hMSH2 gene: correction for ascertainment. J Med Genet 42(6):491–496

    Article  CAS  PubMed  Google Scholar 

  15. Watson P, Lynch HT (2001) Cancer risk in mismatch repair gene mutation carriers. Fam Cancer 1(1):57–60

    Article  CAS  PubMed  Google Scholar 

  16. Lynch HT, Lynch J (2000) Lynch syndrome: genetics, natural history, genetic counseling, and prevention. J Clin Oncol 18(21 suppl):19S–31S

    CAS  PubMed  Google Scholar 

  17. Mitchell RJ, Farrington SM, Dunlop MG, Campbell H (2002) Mismatch repair genes hMLH1 and hMSH2 and colorectal cancer: a HuGEreview. Am J Epidemiol 156(10):885–902

    Article  CAS  PubMed  Google Scholar 

  18. Vasen HF, Möslein G, Alonso A, Bernstein I, Bertario L, Blanco I, Burn J, Capella G, Engel C, Frayling I, Friedl W, Hes FJ, Hodgson S, Mecklin JP, Møller P, Nagengast F, Parc Y, Renkonen-Sinisalo L, Sampson JR, Stormorken A, Wijnen J (2007) Guidelines for the clinical management of Lynch syndrome (hereditary non-polyposis cancer). J Med Genet 44(6):353–362

    Article  CAS  PubMed  Google Scholar 

  19. Renkonen-Sinisalo L, Bützow R, Leminen A, Lehtovirta P, Mecklin JP, Järvinen HJ (2007) Surveillance for endometrial cancer in hereditary nonpolyposis colorectal cancer syndrome. Int J Cancer 120(4):821–824

    Article  CAS  PubMed  Google Scholar 

  20. Dove-Edwin I, Boks D, Goff S, Kenter GG, Carpenter R, Vasen HF, Thomas HJ (2002) The outcome of endometrial carcinoma surveillance by ultrasound scan in women at risk of hereditary nonpolyposis colorectal carcinoma and familial colorectal carcinoma. Cancer 94(6):1708–1712

    Article  PubMed  Google Scholar 

  21. Boilesen AE, Bisgaard ML, Bernstein I (2008) Risk of gynecologic cancers in Danish hereditary non-polyposis colorectal cancer families. Acta Obstet Gynecol Scand 87(11):1129–1135

    Article  PubMed  Google Scholar 

  22. Blokhuis MM, Goldberg PA, Pietersen GE, Algar U, Vorster AA, Govender D, Ramesar RS (2008) The extracolonic cancer spectrum in females with the common ‘South African’ hMLH1 c. C1528T mutation. Fam Cancer 7(3):191–198 (Epub 2007)

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to D. A. Stupart.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Stupart, D.A., Goldberg, P.A., Algar, U. et al. Cancer risk in a cohort of subjects carrying a single mismatch repair gene mutation. Familial Cancer 8, 519–523 (2009). https://doi.org/10.1007/s10689-009-9281-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10689-009-9281-5

Keywords

Navigation